新青年麻醉论坛

 找回密码
 会员注册

QQ登录

只需一步,快速开始

快捷登录

搜索
热搜: 麻醉 视频 中级
查看: 3104|回复: 2
打印 上一主题 下一主题

[读书交流] 危重病人术中输注生理盐水还是乳酸林格氏溶液?

[复制链接]
跳转到指定楼层
1#
发表于 2020-4-4 21:22:00 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式

Infusion of large volumes of saline solution can cause hyperchloremic metabolic acidosis.
输注大量生理盐水可引起高氯性代谢性酸中毒
Lactated Ringer’s solution contains less chloride, reducing the risk of hyperchloremic metabolic acidosis.
乳酸林格氏溶液含氯化物较少,减少高氯酸盐代谢性酸中毒的风险
The hypothesis that a composite of in-hospital mortality and major postoperative complications would be lower in patients administered lactated Ringer’s solution than in those administered saline solution was tested in patients having colorectal or orthopedic surgery.
假设结直肠或矫形外科手术患者中乳酸林格液组住院死亡率和主要术后并发症低于生理盐水使用组的患者。

In an alternating cohort controlled trial, 4,187 (49%) patients were assigned to receive lactated Ringer’s solution and 4,429 (51%) were assigned to receive normal saline solution. Patients were given a median of nearly 2 l of lactated Ringer’s or saline solution in less than 4 h.
在一项交替队列对照试验中,4,187例(49%)患者被分配接受乳酸林格液组,4,429例(51%)被分配接受生理盐水组。在不到4小时内 患者 使用乳酸林格氏液或盐水溶液的中位数为近2l。


The primary composite of in-hospital mortality and major complications (moderate or severe acute kidney injury, infections, respiratory complications, and hemorrhage) was observed in 5.8% of lactated Ringer’s and 6.1% of normal saline patients (absolute difference –0.3%; 95% CI, –1.3% to 0.7%).
我们观察到5.8%乳酸林格氏液组和6.1%的生理盐水组患者(中度或重度急性肾损伤、感染、呼吸道并发症和出血)住院死亡率和主要并发症的主要综合因素
Using an intent-to-treat approach, the estimated average relative risk of lactated Ringer’s versus saline solution across the individual components was 1.16 (95% CI, 0.89 to 1.52). 采用意向治疗目标导向治疗方法,乳酸林格氏相比于生理盐水平均相对风险1.16倍(95% CI, 0.89 to 1.52)
SeetheaccompanyingEditorialonpage609.(Summary:M.J.Avram.Image:S.M.Jarret,M.F.A.,C.M.I./J.P.Rathmell.)

楼主热帖

马上注册,享用更多功能,让你轻松玩转论坛

您需要 登录 才可以下载或查看,没有帐号?会员注册

x
2#
 楼主| 发表于 2020-4-4 21:23:17 | 只看该作者
[img][/img]

友情提示:转载请注意注明作者和出处!!

回复 支持 反对

使用道具 举报/纠错

3#
 楼主| 发表于 2020-4-5 08:46:05 | 只看该作者
        Cannabis Use Disorder and Perioperative Outcomes in Major Elective Surgeries: A Retrospective Cohort Analysis
                      大使用障碍择期手术围手术期手术的结果:回顾性队列分析

Surgical patients with an active cannabis use disorder may be at an increased risk of adverse outcomes given the potential for psychoactive and hemodynamic effects within the perioperative setting.
持续性大麻使用障碍的外科患者因为在围手术期可能会产生精神和血流动力学效应而产生不良果的风险。
A retrospective cohort study was conducted to test the hypothesis that nonambulatory surgery patients with an active cannabis use disorder have a higher risk of postoperative complications using data obtained from the Nationwide Inpatient Sample from 2006 to 2015.
2006年至2015年获得的全国住院样本中进行了一项回顾性队列研究,以检验非卧床手术患者有活动性大麻使用障碍术后并发症更高风险假设  
The primary composite outcome consisted of clinically relevant postoperative complications, including myocardial infarction, stroke, sepsis, deep vein thrombosis/pulmonary embolus, acute kidney injury requiring dialysis, respiratory failure, and in-hospital mortality.
主要综合结果包括临床相关的术后并发症,包括心肌梗死、中风、脓毒症、深静脉血栓形成/肺栓塞、急性肾损伤 需要透析、呼吸衰竭和住院死亡率。
A propensity score matched-pairs analysis of the cohort was used to evaluate the adjusted association between active cannabis use disorders and the outcome of interest; the matched-pairs cohort consisted of 13,603 patients in each group.
                                             使用倾向性得分配对分析来评估活跃的大麻使用障碍与临床结果之间关联;配对队列每组13603例。
There was no statistically significant difference in the composite perioperative outcome between patients with (400 of 13,603; 2.9%) and without (415 of 13,603; 3.1%) a reported active cannabis use disorder (adjusted odds ratio 0.97; 95% CI, 0.84 to 1.11).
报告的大麻使用活跃的患者(13,603例中有400例;2.9%)和未报告的(13,603例中有415例;3.1%)的综合围手术期结果无统计学差异 等序(调整优势比0.9795%CI0.841.11) See theaccompanying Editorial on page 612. (Summary: M. J. Avram. Image: Adobe Stock.)


友情提示:转载请注意注明作者和出处!!

回复 支持 反对

使用道具 举报/纠错

您需要登录后才可以回帖 登录 | 会员注册

本版积分规则


论坛郑重声明 本站供网上自由讨论使用,所有个人言论并不代表本站立场,所发布资源均来源于网络,假若內容有涉及侵权,请联络我们。我们将立刻删除侵权资源,并向版权所有者致以诚挚的歉意!
收藏帖子 返回列表 联系我们 搜索 官方QQ群

QQ|关于我们|业务合作|手机版|新青年麻醉论坛 ( 浙ICP备19050841号-1 )

GMT+8, 2025-1-23 13:09 , Processed in 0.155663 second(s), 24 queries , Gzip On.

Powered by Discuz! X3.2

© 2001-2013 Comsenz Inc.

快速回复 返回顶部 返回列表